Inventor
SOMMER ANDREAS
US32 patents
⚠️ This page may combine multiple inventors who share the name “SOMMER ANDREAS”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
AUSPEX PHARMACEUTICALS INC
9 patentsUS10166183B2Jan 1, 2019
Pharmaceutical formulations
AUSPEX PHARMACEUTICALS INC22 citations93
US9296739B2Mar 29, 2016
Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2
AUSPEX PHARMACEUTICALS INC21 citations91
US9233959B2Jan 12, 2016
Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2
AUSPEX PHARMACEUTICALS INC22 citations91
US9814708B2Nov 14, 2017
Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2
AUSPEX PHARMACEUTICALS INC6 citations83
US9346800B2May 24, 2016
Formulations pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2
AUSPEX PHARMACEUTICALS INC9 citations83
US9550780B2Jan 24, 2017
Formulations pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2
AUSPEX PHARMACEUTICALS INC4 citations72
US10966922B2Apr 6, 2021
Pharmaceutical formulations
AUSPEX PHARMACEUTICALS INC0 citations62
US11666566B2Jun 6, 2023
Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2
AUSPEX PHARMACEUTICALS INC0 citations60
US11033540B2Jun 15, 2021
Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2
AUSPEX PHARMACEUTICALS INC0 citations60
CELTRIX PHARMA
6 patentsUS6040292AMar 21, 2000
Methods for treating diabetes
CELTRIX PHARMA43 citations92
US5643867AJul 1, 1997
Method for treating catabolic conditions
CELTRIX PHARMA19 citations91
US5407913AApr 18, 1995
Method and composition for systemic treatment of tissue injury
CELTRIX PHARMA50 citations91
US6124259ASep 26, 2000
Method for treating ophthalmic disorders with IGFBP
CELTRIX PHARMA29 citations86
US5948757ASep 7, 1999
High dose IGF-1 therapy
CELTRIX PHARMA8 citations70
US5789547AAug 4, 1998
Method of producing insulin-like growth factor-I (IGF-I) and insulin-like growth factor binding protein-3 (IGFBP-3) with correct folding and disulfide bonding
CELTRIX PHARMA6 citations57
SYNERGEN INC
5 patentsUS5075222ADec 24, 1991
Interleukin-1 inhibitors
SYNERGEN INC277 citations97
US5332804AJul 26, 1994
High molecular weight human angiogenic basic fibroblast growth factors
SYNERGEN INC36 citations92
US4994559AFeb 19, 1991
Human basic fibroblast growth factor
SYNERGEN INC83 citations92
US5026839AJun 25, 1991
DNA encoding a basic fibroblast growth factor
SYNERGEN INC37 citations89
US5188943AFeb 23, 1993
Method of producing high molecular weight human fibroblast growth factors
SYNERGEN INC10 citations73